Global Oncology Drugs Market Research Report 2020

Global Oncology Drugs Market Research Report 2020

Table of Contents
1 Oncology Drugs Market Overview
1.1 Product Overview and Scope of Oncology Drugs
1.2 Oncology Drugs Segment by Type
1.2.1 Global Oncology Drugs Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Antimetabolite
1.2.3 Alkaloid drugs
1.2.4 Hormone
1.2.5 Targeted drug
1.2.6 Platinum-based drugs
1.2.7 Others
1.3 Oncology Drugs Segment by Application
1.3.1 Oncology Drugs Sales Comparison by Application: 2020 VS 2026
1.3.2 Blood Cancer
1.3.3 Breast Cancer
1.3.4 Gastrointestinal Cancer
1.3.5 Prostate Cancer
1.3.6 Respiratory/Lung Cancer
1.3.7 Others
1.4 Global Oncology Drugs Market Size Estimates and Forecasts
1.4.1 Global Oncology Drugs Revenue 2015-2026
1.4.2 Global Oncology Drugs Sales 2015-2026
1.4.3 Oncology Drugs Market Size by Region: 2020 Versus 2026
2 Global Oncology Drugs Market Competition by Manufacturers
2.1 Global Oncology Drugs Sales Market Share by Manufacturers (2015-2020)
2.2 Global Oncology Drugs Revenue Share by Manufacturers (2015-2020)
2.3 Global Oncology Drugs Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Oncology Drugs Manufacturing Sites, Area Served, Product Type
2.5 Oncology Drugs Market Competitive Situation and Trends
2.5.1 Oncology Drugs Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Oncology Drugs Players (Opinion Leaders)
3 Oncology Drugs Retrospective Market Scenario by Region
3.1 Global Oncology Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Oncology Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Oncology Drugs Market Facts & Figures by Country
3.3.1 North America Oncology Drugs Sales by Country
3.3.2 North America Oncology Drugs Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Oncology Drugs Market Facts & Figures by Country
3.4.1 Europe Oncology Drugs Sales by Country
3.4.2 Europe Oncology Drugs Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Oncology Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Oncology Drugs Sales by Region
3.5.2 Asia Pacific Oncology Drugs Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Oncology Drugs Market Facts & Figures by Country
3.6.1 Latin America Oncology Drugs Sales by Country
3.6.2 Latin America Oncology Drugs Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Oncology Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Oncology Drugs Sales by Country
3.7.2 Middle East and Africa Oncology Drugs Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Oncology Drugs Historic Market Analysis by Type
4.1 Global Oncology Drugs Sales Market Share by Type (2015-2020)
4.2 Global Oncology Drugs Revenue Market Share by Type (2015-2020)
4.3 Global Oncology Drugs Price Market Share by Type (2015-2020)
4.4 Global Oncology Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Oncology Drugs Historic Market Analysis by Application
5.1 Global Oncology Drugs Sales Market Share by Application (2015-2020)
5.2 Global Oncology Drugs Revenue Market Share by Application (2015-2020)
5.3 Global Oncology Drugs Price by Application (2015-2020)
6 Company Profiles and Key Figures in Oncology Drugs Business
6.1 Roche
6.1.1 Corporation Information
6.1.2 Roche Description, Business Overview and Total Revenue
6.1.3 Roche Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Roche Products Offered
6.1.5 Roche Recent Development
6.2 HENGRUI
6.2.1 HENGRUI Oncology Drugs Production Sites and Area Served
6.2.2 HENGRUI Description, Business Overview and Total Revenue
6.2.3 HENGRUI Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.2.4 HENGRUI Products Offered
6.2.5 HENGRUI Recent Development
6.3 AstraZeneca
6.3.1 AstraZeneca Oncology Drugs Production Sites and Area Served
6.3.2 AstraZeneca Description, Business Overview and Total Revenue
6.3.3 AstraZeneca Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.3.4 AstraZeneca Products Offered
6.3.5 AstraZeneca Recent Development
6.4 QILU
6.4.1 QILU Oncology Drugs Production Sites and Area Served
6.4.2 QILU Description, Business Overview and Total Revenue
6.4.3 QILU Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 QILU Products Offered
6.4.5 QILU Recent Development
6.5 Sanofi
6.5.1 Sanofi Oncology Drugs Production Sites and Area Served
6.5.2 Sanofi Description, Business Overview and Total Revenue
6.5.3 Sanofi Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Sanofi Products Offered
6.5.5 Sanofi Recent Development
6.6 HANSOH
6.6.1 HANSOH Oncology Drugs Production Sites and Area Served
6.6.2 HANSOH Description, Business Overview and Total Revenue
6.6.3 HANSOH Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.6.4 HANSOH Products Offered
6.6.5 HANSOH Recent Development
6.7 LUYE
6.6.1 LUYE Oncology Drugs Production Sites and Area Served
6.6.2 LUYE Description, Business Overview and Total Revenue
6.6.3 LUYE Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.4.4 LUYE Products Offered
6.7.5 LUYE Recent Development
6.8 Novartis
6.8.1 Novartis Oncology Drugs Production Sites and Area Served
6.8.2 Novartis Description, Business Overview and Total Revenue
6.8.3 Novartis Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.8.4 Novartis Products Offered
6.8.5 Novartis Recent Development
6.9 GuiZhou YiBai
6.9.1 GuiZhou YiBai Oncology Drugs Production Sites and Area Served
6.9.2 GuiZhou YiBai Description, Business Overview and Total Revenue
6.9.3 GuiZhou YiBai Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.9.4 GuiZhou YiBai Products Offered
6.9.5 GuiZhou YiBai Recent Development
6.10 Lunan
6.10.1 Lunan Oncology Drugs Production Sites and Area Served
6.10.2 Lunan Description, Business Overview and Total Revenue
6.10.3 Lunan Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Lunan Products Offered
6.10.5 Lunan Recent Development
6.11 Eli Lilly and Company
6.11.1 Eli Lilly and Company Oncology Drugs Production Sites and Area Served
6.11.2 Eli Lilly and Company Oncology Drugs Description, Business Overview and Total Revenue
6.11.3 Eli Lilly and Company Oncology Drugs Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eli Lilly and Company Products Offered
6.11.5 Eli Lilly and Company Recent Development
7 Oncology Drugs Manufacturing Cost Analysis
7.1 Oncology Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Oncology Drugs
7.4 Oncology Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Oncology Drugs Distributors List
8.3 Oncology Drugs Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Oncology Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Oncology Drugs by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Oncology Drugs by Type (2021-2026)
10.2 Oncology Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Oncology Drugs by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Oncology Drugs by Application (2021-2026)
10.3 Oncology Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Oncology Drugs by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Oncology Drugs by Region (2021-2026)
10.4 North America Oncology Drugs Estimates and Projections (2021-2026)
10.5 Europe Oncology Drugs Estimates and Projections (2021-2026)
10.6 Asia Pacific Oncology Drugs Estimates and Projections (2021-2026)
10.7 Latin America Oncology Drugs Estimates and Projections (2021-2026)
10.8 Middle East and Africa Oncology Drugs Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Oncology Drugs Sales (BBL) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Oncology Drugs Sales (BBL) Comparison by Application: 2020 VS 2026
Table 3. Global Oncology Drugs Market Size by Type (BBL) (US$ Million) (2020 VS 2026)
Table 4. Global Key Oncology Drugs Manufacturers Covered in This Study
Table 5. Global Oncology Drugs Sales (BBL) by Manufacturers (2015-2020)
Table 6. Global Oncology Drugs Sales Share by Manufacturers (2015-2020)
Table 7. Global Oncology Drugs Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Oncology Drugs Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Oncology Drugs Average Price (USD/BBL) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Oncology Drugs Sales Sites and Area Served
Table 11. Manufacturers Oncology Drugs Product Types
Table 12. Global Oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Oncology Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncology Drugs as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Oncology Drugs Players
Table 16. Global Oncology Drugs Sales (BBL) by Region (2015-2020)
Table 17. Global Oncology Drugs Sales Market Share by Region (2015-2020)
Table 18. Global Oncology Drugs Revenue (Million US$) by Region (2015-2020)
Table 19. Global Oncology Drugs Revenue Market Share by Region (2015-2020)
Table 20. North America Oncology Drugs Sales by Country (2015-2020) (BBL)
Table 21. North America Oncology Drugs Sales Market Share by Country (2015-2020)
Table 22. North America Oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Oncology Drugs Revenue Market Share by Country (2015-2020)
Table 24. Europe Oncology Drugs Sales by Country (2015-2020) (BBL)
Table 25. Europe Oncology Drugs Sales Market Share by Country (2015-2020)
Table 26. Europe Oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Oncology Drugs Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Oncology Drugs Sales by Region (2015-2020) (BBL)
Table 29. Asia Pacific Oncology Drugs Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Oncology Drugs Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Oncology Drugs Revenue Market Share by Region (2015-2020)
Table 32. Latin America Oncology Drugs Sales by Country (2015-2020) (BBL)
Table 33. Latin America Oncology Drugs Sales Market Share by Country (2015-2020)
Table 34. Latin America Oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Oncology Drugs Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Oncology Drugs Sales by Country (2015-2020) (BBL)
Table 37. Middle East and Africa Oncology Drugs Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Oncology Drugs Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Oncology Drugs Revenue Market Share by Country (2015-2020)
Table 40. Global Oncology Drugs Sales (BBL) by Type (2015-2020)
Table 41. Global Oncology Drugs Sales Share by Type (2015-2020)
Table 42. Global Oncology Drugs Revenue (Million US$) by Type (2015-2020)
Table 43. Global Oncology Drugs Revenue Share by Type (2015-2020)
Table 44. Global Oncology Drugs Price (USD/BBL) by Type (2015-2020)
Table 45. Global Oncology Drugs Sales (BBL) by Application (2015-2020)
Table 46. Global Oncology Drugs Sales Market Share by Application (2015-2020)
Table 47. Global Oncology Drugs Sales Growth Rate by Application (2015-2020)
Table 48. Roche Oncology Drugs Corporation Information
Table 49. Roche Description and Business Overview
Table 50. Roche Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 51. Roche Main Product
Table 52. Roche Recent Development
Table 53. HENGRUI Oncology Drugs Corporation Information
Table 54. HENGRUI Corporation Information
Table 55. HENGRUI Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 56. HENGRUI Main Product
Table 57. HENGRUI Recent Development
Table 58. AstraZeneca Oncology Drugs Corporation Information
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 61. AstraZeneca Main Product
Table 62. AstraZeneca Recent Development
Table 63. QILU Oncology Drugs Corporation Information
Table 64. QILU Corporation Information
Table 65. QILU Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 66. QILU Main Product
Table 67. QILU Recent Development
Table 68. Sanofi Oncology Drugs Corporation Information
Table 69. Sanofi Corporation Information
Table 70. Sanofi Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 71. Sanofi Main Product
Table 72. Sanofi Recent Development
Table 73. HANSOH Oncology Drugs Corporation Information
Table 74. HANSOH Corporation Information
Table 75. HANSOH Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 76. HANSOH Main Product
Table 77. HANSOH Recent Development
Table 78. LUYE Oncology Drugs Corporation Information
Table 79. LUYE Corporation Information
Table 80. LUYE Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 81. LUYE Main Product
Table 82. LUYE Recent Development
Table 83. Novartis Oncology Drugs Corporation Information
Table 84. Novartis Corporation Information
Table 85. Novartis Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 86. Novartis Main Product
Table 87. Novartis Recent Development
Table 88. GuiZhou YiBai Oncology Drugs Corporation Information
Table 89. GuiZhou YiBai Corporation Information
Table 90. GuiZhou YiBai Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 91. GuiZhou YiBai Main Product
Table 92. GuiZhou YiBai Recent Development
Table 93. Lunan Oncology Drugs Corporation Information
Table 94. Lunan Corporation Information
Table 95. Lunan Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 96. Lunan Main Product
Table 97. Lunan Recent Development
Table 98. Eli Lilly and Company Oncology Drugs Corporation Information
Table 99. Eli Lilly and Company Corporation Information
Table 100. Eli Lilly and Company Oncology Drugs Sales (BBL), Revenue (Million US$), Price (USD/BBL) and Gross Margin (2015-2020)
Table 101. Eli Lilly and Company Main Product
Table 102. Eli Lilly and Company Recent Development
Table 103. Sales Base and Market Concentration Rate of Raw Material
Table 104. Key Suppliers of Raw Materials
Table 105. Oncology Drugs Distributors List
Table 106. Oncology Drugs Customers List
Table 107. Market Key Trends
Table 108. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 109. Key Challenges
Table 110. Global Oncology Drugs Sales (BBL) Forecast by Type (2021-2026)
Table 111. Global Oncology Drugs Sales Market Share Forecast by Type (2021-2026)
Table 112. Global Oncology Drugs Revenue (Million US$) Forecast by Type (2021-2026)
Table 113. Global Oncology Drugs Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 114. Global Oncology Drugs Sales (BBL) Forecast by Application (2021-2026)
Table 115. Global Oncology Drugs Revenue (Million US$) Forecast by Application (2021-2026)
Table 116. Global Oncology Drugs Sales (BBL) Forecast by Region (2021-2026)
Table 117. Global Oncology Drugs Sales Market Share Forecast by Region (2021-2026)
Table 118. Global Oncology Drugs Revenue Forecast by Region (2021-2026) (US$ Million)
Table 119. Global Oncology Drugs Revenue Market Share Forecast by Region (2021-2026)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Oncology Drugs
Figure 2. Global Oncology Drugs Sales Market Share by Type: 2020 VS 2026
Figure 3. Antimetabolite Product Picture
Figure 4. Alkaloid drugs Product Picture
Figure 5. Hormone Product Picture
Figure 6. Targeted drug Product Picture
Figure 7. Platinum-based drugs Product Picture
Figure 8. Others Product Picture
Figure 9. Global Oncology Drugs Consumption Market Share by Application: 2020 VS 2026
Figure 10. Blood Cancer
Figure 11. Breast Cancer
Figure 12. Gastrointestinal Cancer
Figure 13. Prostate Cancer
Figure 14. Respiratory/Lung Cancer
Figure 15. Others
Figure 16. Global Oncology Drugs Market Size 2015-2026 (US$ Million)
Figure 17. Global Oncology Drugs Sales Capacity (BBL) (2015-2026)
Figure 18. Global Oncology Drugs Market Size Market Share by Region: 2020 Versus 2026
Figure 19. Oncology Drugs Sales Share by Manufacturers in 2020
Figure 20. Global Oncology Drugs Revenue Share by Manufacturers in 2019
Figure 21. The Global 5 and 10 Largest Players: Market Share by Oncology Drugs Revenue in 2019
Figure 22. Oncology Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 23. Global Oncology Drugs Sales Market Share by Region (2015-2020)
Figure 24. Global Oncology Drugs Sales Market Share by Region in 2019
Figure 25. Global Oncology Drugs Revenue Market Share by Region (2015-2020)
Figure 26. Global Oncology Drugs Revenue Market Share by Region in 2019
Figure 27. North America Oncology Drugs Sales Market Share by Country in 2019
Figure 28. North America Oncology Drugs Revenue Market Share by Country in 2019
Figure 29. U.S. Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 30. U.S. Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 31. Canada Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 32. Canada Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 33. Europe Oncology Drugs Sales Market Share by Country in 2019
Figure 34. Europe Oncology Drugs Revenue Market Share by Country in 2019
Figure 35. Germany Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 36. Germany Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 37. France Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 38. France Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 39. U.K. Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 40. U.K. Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 41. Italy Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 42. Italy Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 43. Russia Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 44. Russia Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 45. Asia Pacific Oncology Drugs Sales Market Share by Region in 2019
Figure 46. Asia Pacific Oncology Drugs Revenue Market Share by Region in 2019
Figure 47. China Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 48. China Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 49. Japan Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 50. Japan Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 51. South Korea Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 52. South Korea Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 53. India Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 54. India Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 55. Australia Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 56. Australia Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 57. Taiwan Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 58. Taiwan Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 59. Indonesia Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 60. Indonesia Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 61. Thailand Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 62. Thailand Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 63. Malaysia Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 64. Malaysia Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 65. Philippines Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 66. Philippines Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 67. Vietnam Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 68. Vietnam Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 69. Latin America Oncology Drugs Sales Market Share by Country in 2019
Figure 70. Latin America Oncology Drugs Revenue Market Share by Country in 2019
Figure 71. Mexico Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 72. Mexico Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 73. Brazil Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 74. Brazil Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 75. Argentina Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 76. Argentina Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 77. Middle East and Africa Oncology Drugs Sales Market Share by Country in 2019
Figure 78. Middle East and Africa Oncology Drugs Revenue Market Share by Country in 2019
Figure 79. Turkey Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 80. Turkey Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 81. Saudi Arabia Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 82. Saudi Arabia Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 83. U.A.E Oncology Drugs Sales Growth Rate (2015-2020) (BBL)
Figure 84. U.A.E Oncology Drugs Revenue Growth Rate (2015-2020) (US$ Million)
Figure 85. Sales Market Share of Oncology Drugs by Type (2015-2020)
Figure 86. Sales Market Share of Oncology Drugs by Type in 2019
Figure 87. Revenue Share of Oncology Drugs by Type (2015-2020)
Figure 88. Revenue Market Share of Oncology Drugs by Type in 2019
Figure 89. Global Oncology Drugs Sales Growth by Type (2015-2020) (BBL)
Figure 90. Global Oncology Drugs Sales Market Share by Application (2015-2020)
Figure 91. Global Oncology Drugs Sales Market Share by Application in 2019
Figure 92. Global Revenue Share of Oncology Drugs by Application (2015-2020)
Figure 93. Global Revenue Share of Oncology Drugs by Application in 2020
Figure 94. Roche Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. HENGRUI Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. QILU Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Sanofi Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. HANSOH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. LUYE Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Novartis Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. GuiZhou YiBai Total Revenue (US$ Million): 2019 Compared with 2018
Figure 103. Lunan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 104. Eli Lilly and Company Total Revenue (US$ Million): 2019 Compared with 2018
Figure 105. Price Trend of Key Raw Materials
Figure 106. Manufacturing Cost Structure of Oncology Drugs
Figure 107. Manufacturing Process Analysis of Oncology Drugs
Figure 108. Oncology Drugs Industrial Chain Analysis
Figure 109. Channels of Distribution
Figure 110. Distributors Profiles
Figure 111. Porter's Five Forces Analysis
Figure 112. North America Oncology Drugs Sales (BBL) and Growth Rate Forecast (2021-2026)
Figure 113. North America Oncology Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 114. Europe Oncology Drugs Sales (BBL) and Growth Rate Forecast (2021-2026)
Figure 115. Europe Oncology Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 116. Latin America Oncology Drugs Sales (BBL) and Growth Rate Forecast (2021-2026)
Figure 117. Latin America Oncology Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 118. Middle East and Africa Oncology Drugs Sales (BBL) and Growth Rate Forecast (2021-2026)
Figure 119. Middle East and Africa Oncology Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 120. Asia Pacific Oncology Drugs Sales (BBL) and Growth Rate Forecast (2021-2026)
Figure 121. Asia Pacific Oncology Drugs Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 122. Bottom-up and Top-down Approaches for This Report
Figure 123. Data Triangulation
Figure 124. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global 5-Fluorouracil Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76

The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......

Global Carboplatin Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......

Global Neutropenia Drugs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96

The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......

Global Small Molecule Cancer Drug Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......

Global Capecitabine Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80

Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......

Global Oxaliplatin Market Research Report 2024

Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104

Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......

Global Cancer Treatment Drugs Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158

According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......

Global Capecitabine Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93

According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......

Global Methotrexate Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95

According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs